Abstract
Until recently it was believed that TNF-induced apoptosis is mediated exclusively by TNF-RI because TNF-RII lacks death domain. However, it has been demonstrated that TNF-RII enhances TNF-RI-mediated apoptosis. In this review, I have discussed the evidence and mechanisms by which TNF-RII regulates TNF-alpha-induced apoptosis. A role of RIP is emphasized and novel mechanisms of FLIP-mediated inhibition of apoptosis are discussed. In addition, various mechanisms of TNF-induced activation of mitochondrial pathway of apoptosis have been reviewed.
Keywords: Tumor Necrosis Factor, Receptor-Mediated Apoptosis, Tumor necrosis factor (TNF-a), TNFRI, TRADD (TNF receptor-associated death-domain), TRAF-2, MAP kinase, NFkB
Current Molecular Medicine
Title: Molecular Steps of Tumor Necrosis Factor Receptor-Mediated Apoptosis
Volume: 1 Issue: 3
Author(s): S. Gupta
Affiliation:
Keywords: Tumor Necrosis Factor, Receptor-Mediated Apoptosis, Tumor necrosis factor (TNF-a), TNFRI, TRADD (TNF receptor-associated death-domain), TRAF-2, MAP kinase, NFkB
Abstract: Until recently it was believed that TNF-induced apoptosis is mediated exclusively by TNF-RI because TNF-RII lacks death domain. However, it has been demonstrated that TNF-RII enhances TNF-RI-mediated apoptosis. In this review, I have discussed the evidence and mechanisms by which TNF-RII regulates TNF-alpha-induced apoptosis. A role of RIP is emphasized and novel mechanisms of FLIP-mediated inhibition of apoptosis are discussed. In addition, various mechanisms of TNF-induced activation of mitochondrial pathway of apoptosis have been reviewed.
Export Options
About this article
Cite this article as:
Gupta S., Molecular Steps of Tumor Necrosis Factor Receptor-Mediated Apoptosis, Current Molecular Medicine 2001; 1 (3) . https://dx.doi.org/10.2174/1566524013363780
DOI https://dx.doi.org/10.2174/1566524013363780 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimers Disease Drug Development: Old Problems Require New Priorities
CNS & Neurological Disorders - Drug Targets Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Ophthalmological and Otological Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Molecular Pathology in Neurodegenerative Diseases
Current Drug Targets Editorial [Hot Topic: The Therapeutic Potential of FOXO Proteins (Guest Editor: Wolfgang Link)]
Current Drug Targets Metal Catalyzed Oxidation of Alpha-Synuclein – A Role for Oligomerization in Pathology?
Current Alzheimer Research The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease
Current Pharmaceutical Design Hippocampal Neurogenesis, Neurotrophic Factors and Depression: Possible Therapeutic Targets?
CNS & Neurological Disorders - Drug Targets Induced Pluripotent Stem Cells and Their Potential for Basic and Clinical Sciences
Current Cardiology Reviews Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders
Current Gene Therapy Pharmacogenetic Applications of the Post Genomic Era
Current Pharmaceutical Biotechnology Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
Mini-Reviews in Medicinal Chemistry Clinical Analysis Methods of Voice Disorders
Current Bioinformatics Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Current Gene Therapy Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Limited Hypotensive Effect of Sildenafil in a High-Risk Population: A Preliminary Report
Current Drug Safety Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases
Current Pharmaceutical Design Dogs with Cognitive Dysfunction Syndrome: A Natural Model of Alzheimer’s Disease
Current Alzheimer Research Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Nephroangiosclerosis and Its Pharmacological Approach
Current Vascular Pharmacology